Kewaunee Scientific Corporation reported earnings results for the fourth quarter and full year ended April 30, 2023. For the fourth quarter, the company reported sales was USD 53.99 million compared to USD 49.72 million a year ago. Net income was USD 1.01 million compared to net loss of USD 0.362 million a year ago. Basic earnings per share from continuing operations was USD 0.36 compared to basic loss per share from continuing operations of USD 0.13 a year ago. Diluted earnings per share from continuing operations was USD 0.34 compared to diluted loss per share from continuing operations of USD 0.13 a year ago.
For the full year, sales was USD 219.49 million compared to USD 168.87 million a year ago. Net income was USD 0.738 million compared to net loss of USD 6.13 million a year ago. Basic earnings per share from continuing operations was USD 0.26 compared to basic loss per share from continuing operations of USD 2.2 a year ago. Diluted earnings per share from continuing operations was USD 0.25 compared to diluted loss per share from continuing operations of USD 2.2 a year ago.